Masafumi Seki

26PUBLICATIONS
15CO-AUTHORS
Medical infection agents (incl. prions)NeonatologyPharmacogenomicsIntensive careAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 17, 2026
Bacteremic Group A Streptococcal Co-Infection in Two Adults with H3N2 Influenza in Japan, 2025-2026: A Case Series.

|Jul 15, 2026
Adult Empyema Caused by Refractory Methicillin-Resistant Staphylococcus aureus Treated Using Linezolid as Salvage Therapeutic Option: A Report of Two Cases.

|May 19, 2026
Recurrent/Refractory Multidrug- and Pre-Multidrug-Resistant Pseudomonas aeruginosa Infection Cases Maintained by Long-Term, Low-Dose Macrolide Administration.

|Apr 28, 2026
Development of Pseudomonas aeruginosa Drug Resistant Due to Prolonged Use of Broad-Spectrum Antibiotics in Severe Viral Infection/Candidemia Cases.

|Mar 30, 2026
Assessing the Lower Incidence of Invasive Pneumococcal Diseases in Japan During the COVOD-19 Pandemic.

Masafumi Seki, Daishi Shimada

|Dec 26, 2025
Adult Influenza Patients Diagnosed by Multiplex Polymerase Chain Reaction Tests, but Not Rapid Antigen Tests, and Managed Successfully During the 2024 to 2025 Major Influenza-Endemic Season in a Tertiary Hospital in Japan.

Masafumi Seki

Pageof 5

Frequent Collaborators

6 joint publications

Yuji Watanabe

5 joint publications

Daishi Shimada

3 joint publications

Kotaro Mitsutake

1 joint publications

Kouji Okada